Showing results 26 to 45 of 55
< previous
next >
| Issue Date | Title | Sub-Title | Author(s) | Journal Name | Volume Number | Issue Number | Pages |
| 2014 | Invited lecture for canadian Institutes of health research & Karnataka health promotion Trust’s | - | Chatterjee, Chirantan | | | | |
| 2016 | IPR and composition of tasks | - | Bhattacharya, Sourav ; Chakraborty, Pavel ; Chatterjee, Chirantan | | | | |
| 13-Nov-2015 | Is India ready to reset its innovation mojo? | - | Chatterjee, Chirantan | LiveMint | | | |
| 3-Sep-2015 | Is the new 'Mann der Tats' changing Indian society? | - | Chatterjee, Chirantan | Hindustan Times | | | |
| 2011 | It’s time for De-Novo thinking in Indian pharmaceutical policy making | - | Chatterjee, Chirantan | | | | |
| 17-Jan-2015 | It’s time to ratchet up India’s intellectual property stance | - | Chatterjee, Chirantan | Hindustan Times | | | |
| 2013 | Killing the golden goose or just chasing it around the farmyard?: Generic entry and the incentives for early-stage pharmaceutical innovation | - | Branstetter, Lee ; Chatterjee, Chirantan ; Higgins, Matthew John | | | | |
| 2011 | Learning by exporting: The contingent role of capabilities | - | Chatterjee, Chirantan ; Nandkumar, Anand ; Dhanaraj, Charles | | | | |
| 2015 | Life sciences symposium | - | Chatterjee, Chirantan | | | | |
| 2016 | Maximizing local value addition in Indian mobile phone manufacturing: a practical phased approach | - | Pathak, Tarun ; Chatterjee, Chirantan ; Shah, Neil | | | | 62p. |
| 2017 | Mitigating regulatory impact : the case of partial price controls on metformin in India | - | Bhaskarabhatla, Ajay ; Chatterjee, Chirantan ; Anurag, Priyatam ; Pennings, Enrico | Health Policy And Planning | Vol.32 | Iss.2 | 194-204p. |
| 2014 | Panel invitee, globalizing innovation: The current Discourse | - | Chatterjee, Chirantan | | | | |
| 2015 | Patents and technology standards: The data sets | - | Chatterjee, Chirantan | | | | |
| 6-Mar-2015 | Physicians/doctors and their role in cartels and irrational bundling of combination drugs in Indian pharmaceutical industry | - | Chatterjee, Chirantan | | | | |
| 2014 | Regional differences in first mover advantages | - | Chatterjee, Chirantan | | | | |
| 2011 | Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry | - | Branstetter, Lee G ; Chatterjee, Chirantan ; Higgins, Matthew J | | | | 41p. |
| 2016 | Regulation and welfare: Evidence from paragraph IV generic entry in the pharmaceutical industry | - | Branstetter, Lee ; Chatterjee, Chirantan ; Higgins, Matthew J | Rand Journal of Economics | Vol.47 | Iss.4 | 857-890p. |
| 1-Apr-2013 | Regulation, competition, and innovation in the global bio-pharmaceutical industry? | - | Chatterjee, Chirantan | | | | |
| 2014 | Retail union and regional first mover advantages | - | Bhaskarabhatla, Ajay ; Chatterjee, Chirantan ; Karreman, Bas | | | | |
| 2016 | Starving (or Fattening) the Golden Goose?: Generic entry and the incentives for early stage pharmaceutical innovation | - | Branstetter, Lee ; Chatterjee, Chirantan ; Higgins, Matthew John | | | | |
